Annual report [Section 13 and 15(d), not S-K Item 405]

Restatement of Previously Issued Financial Statements - Schedule of Condensed Consolidated Statements of Operations (Details)

v3.25.1
Restatement of Previously Issued Financial Statements - Schedule of Condensed Consolidated Statements of Operations (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Condensed Income Statements, Captions [Line Items]    
Revenue $ 110,451 $ 97,612
Cost of revenue 70,560 59,024
Gross profit 39,891 38,588
Research and development 29,188 27,650
General and administrative 49,744 41,999
Total operating expenses 108,625 97,368
Loss from operations (68,734) (58,780)
Other expense, net (1,912) (2,272)
Loss before income taxes (102,659) (77,700)
Income tax provision (benefit) 159 (142)
Net loss $ (102,818) $ (77,558)
Basic net loss per share $ (4.26) $ (3.96)
Diluted net loss per share $ (4.26) $ (3.96)
Weighted-average shares used in computing basic net loss per share 24,159,770 19,580,006
Weighted-average shares used in computing diluted net loss per share 24,159,770 19,580,006